Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy
Open Access
- 24 December 2020
- Vol. 10 (1), 14
- https://doi.org/10.3390/cells10010014
Abstract
The adoptive transfer of the chimeric antigen receptor (CAR) expressing T-cells has produced unprecedented successful results in the treatment of B-cell malignancies. However, the use of this technology in other malignancies remains less effective. In the setting of solid neoplasms, CAR T-cell metabolic fitness needs to be optimal to reach the tumor and execute their cytolytic function in an environment often hostile. It is now well established that both tumor and T cell metabolisms play critical roles in controlling the immune response by conditioning the tumor microenvironment and the fate and activity of the T cells. In this review, after a brief description of the tumoral and T cell metabolic reprogramming, we summarize the latest advances and new strategies that have been developed to improve the metabolic fitness and efficacy of CAR T-cell products.Funding Information
- Fondazione Umberto Veronesi (3581)
This publication has 127 references indexed in Scilit:
- Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor functionJCI Insight, 2013
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory DevelopmentImmunity, 2012
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progressionTrends in Immunology, 2010
- Hypoxia-Inducible Factors as Essential Regulators of InflammationPublished by Springer Science and Business Media LLC ,2010
- T‐cell exhaustion: characteristics, causes and conversionImmunology, 2010
- Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxiaBlood, 2009
- The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammationNature Immunology, 2009
- IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survivalBlood, 2008
- Orchestration of lymphocyte chemotaxis by mitochondrial dynamicsThe Journal of Experimental Medicine, 2006
- A2A adenosine receptor protects tumors from antitumor T cellsProceedings of the National Academy of Sciences of the United States of America, 2006